Medical researchers are going to subject healthy young black men to ctic acidosis (a buildup of acid in the blood that can lead to a medical emergency), nausea, vomiting, unusual muscle pain and/or weakness, a high potential for serious liver problems, an increased risk of kidney damage and potential bone damage,
Of course, this isn't Nazi Germany, so the medical experiments will be purely voluntary. The incentive to participate is simple, compelling and seductive. These otherwise healthy young black men who are either too macho or too lazy to use condoms can bareback their little hearts out on the chance that the "prophylactic" use of HIV treatment drugs such as Gilead Science's Viread and Truvada will prevent infection by the HIV virus.

The theory, known as pre-exposure prophylaxis (PrEP), suggests that taking anti- HIV drugs before exposure to the virus can protect a person against infection when they are exposed to it through sex or intravenous drug use. It's controversial because it may raise resistance to the drugs, making them less effective when infection happens. And since gay black men are the study subjects, the high risk of dangerous drug side effects seems to be of little concern to the United States government researchers.

``We don't yet have definitive proof this is effective,'' Dawn Smith, the Centers for Disease Control and Prevention told a reporter for Bloomberg News.
Unlike other experimental approaches to fighting HIV such as vaccines and microbicides, PrEP uses drugs that are already in use, such as Gilead Sciences Inc.'s Viread and Truvada. The technique has been shown to lower the risk of infection in monkeys.
According to the CDC, "The U.S. trial will target young homosexual black males because they are statistically more at risk of contracting HIV than their white peers."
Can you count the number of things that are wrong with this picture? Of course, if I were a true cynic, I might even applaud the pharmaceutical company for concocting a brilliant marketing scheme designed to dramatically expand sales. The HIV positive population is so very small, but the HIV negative population? Now there's a marketing opportunity beyond compare! Heck, even without an FDA approved indication, the publicity for this trial alone will drive thousands of affluent gay men into their doctor's offices for a lovely happy hour prophylaxis drug cocktail. Who needs condoms when I can sell my liver for a daily hit of Truvada?
Most Commented